Texas Attorney General Paxton is filing a lawsuit against the makers of acetaminophen, claiming the corporations withheld potential risks that the medication presented to children's brain development.
The lawsuit follows a month after President Donald Trump promoted an unproven link between using Tylenol - also known as paracetamol - throughout gestation and autism spectrum disorder in offspring.
The attorney general is taking legal action against the pharmaceutical giant, which once produced the medication, the only pain reliever approved for expectant mothers, and the current manufacturer, which currently produces it.
In a declaration, he stated they "betrayed America by profiting off of suffering and marketing drugs ignoring the potential hazards."
The company says there is insufficient reliable data connecting Tylenol to autism.
"These corporations lied for decades, deliberately risking numerous people to increase profits," the attorney general, from the Republican party, declared.
The manufacturer said in a statement that it was "seriously troubled by the perpetuation of misinformation on the security of paracetamol and the likely effects that could have on the health of US mothers and children."
On its official site, Kenvue also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a proven link between consuming paracetamol and autism spectrum disorder."
Groups representing physicians and medical practitioners share this view.
The leading OB-GYN organization has stated paracetamol - the main ingredient in acetaminophen - is a restricted selection for women during pregnancy to manage pain and fever, which can create significant medical dangers if ignored.
"In more than two decades of investigation on the use of paracetamol in pregnancy, no reliable research has successfully concluded that the use of acetaminophen in any stage of pregnancy causes brain development issues in offspring," the association stated.
The court filing cites current declarations from the Trump administration in arguing the drug is potentially dangerous.
In recent weeks, Trump raised alarms from medical authorities when he advised pregnant women to "fight like hell" not to use Tylenol when unwell.
The FDA then issued a notice that physicians should consider limiting the usage of Tylenol, while also mentioning that "a causal relationship" between the medication and autism in children has not been established.
The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in April to undertake "a massive testing and research effort" that would identify the origin of autism spectrum disorder in a limited time.
But authorities advised that identifying a unique factor of autism spectrum disorder - believed by scientists to be the consequence of a complex mix of inherited and external influences - would be difficult.
Autism is a category of lifelong neurodivergence and condition that affects how persons experience and relate to the surroundings, and is recognized using physician assessments.
In his lawsuit, the attorney general - a Trump ally who is running for the Senate - asserts Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the research" around acetaminophen and autism.
The case seeks to make the companies "remove any commercial messaging" that claims acetaminophen is reliable for pregnant women.
The Texas lawsuit echoes the complaints of a group of guardians of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in recently.
A federal judge dismissed the lawsuit, saying investigations from the plaintiffs' authorities was not conclusive.